Global private equity and venture capital news and research

Posts Tagged ‘Aisling Capital’

28 October 2014

Syros lands $53m from eight VC firms

pills-pills-pills-4-606633-m Eight venture capital firms have participated in a $53m Series B financing round for gene control therapies company Syros Pharmaceuticals.

8 May 2014

NEA joins Aisling, OrbiMed to back cancer treatment business Loxo with $24m

life science test tube_sq Venture capital major New Enterprise Associates has led a $24m Series B financing round for cancer-focused biopharmaceutical business Loxo Oncology.

24 March 2014

Venture capital-backed Versartis soars after IPO

Venture capital-backed Versartis soars after IPO

18 December 2013

Cancer treatment company ViewRay secures $30m

mri Medical devices company ViewRay has raised a $30m round, which was backed by new investor Cowealth Medical Holding.

8 October 2013

Sofinnova Ventures leads $20m Series D for biotech company Versartis

biotech_lrg Sofinnova Ventures has led a $20m Series D round for Versartis to help the biotech company prepare for an international Phase 3 pediatric trial of VRS-317, a treatmet for patients with growth hormone deficiency.

3 October 2013

Lensar interest heats up with new $87 debt, equity investments

A trio of venture capital investors have backed laser cataract surgery business Lensar with $27m of equity financing.

12 June 2013

Swift part-exit for Longitude as Esperion eyes IPO weeks after investmentp

Venture investors in biopharmaceutical business Esperion Therapeutics are preparing to sell down their stakes through an IPO just weeks after the company completed a $33m preferred financing round.

6 November 2012

US biopharma Ambit Biosciences nets $25m tranche of $50m financing

US biopharmaceutical company Ambit Biosciences has closed the first $25m tranche of a new $50m preferred stock financing, led by existing investor OrbiMed Advisors.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015